Startups
Oncode Institute is an independent institute dedicated to understanding cancer and translating research into practice. Oncode, starting from a deeper understanding of the basics of cancer, works to come up with better treatments and improved diagnostics.
Our goal: helping more patients survive, improving the quality of life for those afflicted, and ultimately curing cancer.
The complexity of cancer calls for strategic action and collaboration. Instead of new buildings, we are constructing a network, in which experienced, leading scientists and gifted young researchers at partner institutions strive together toward a greater, common goal, supported by KWF Kankerbestrijding and the Dutch Government. Because only by working together we can outsmart cancer.
Official launch on February 5th, 2018
If you have any questions or suggestions, please feel free to contact us at anytime.
[email protected]
Our goal: helping more patients survive, improving the quality of life for those afflicted, and ultimately curing cancer.
The complexity of cancer calls for strategic action and collaboration. Instead of new buildings, we are constructing a network, in which experienced, leading scientists and gifted young researchers at partner institutions strive together toward a greater, common goal, supported by KWF Kankerbestrijding and the Dutch Government. Because only by working together we can outsmart cancer.
Official launch on February 5th, 2018
If you have any questions or suggestions, please feel free to contact us at anytime.
[email protected]
Overview
Location
Netherlands, Utrecht
Employees
11-50
Total raised
$297.89K
Founded date
2017
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 31, 2026 | Laigo Bio: €17 Million Raised For Biotech Developing SureTACs Precision Protein Degradation Platform | Laigo Bio, a Netherlands-based biotech company developing targeted protein degradation therapies, has completed the final close of its oversubscribed seed financing round, bringing the total raised to €17 million. The latest tranche include... |
| Mar 23, 2026 | Laigo Bio Closes €17M Seed Funding | Laigo Bio, an Utrecht, The Netherlands-based biotech company, closed the second close of its seed financing round, securing an additional €5.5m, bringing the total raised to €17m. This latest investment comes from new co-lead investor Biova... |
| Dec 4, 2025 | Targeting the “undruggable”: Laigo Bio secures €11.5 million to advance its SureTAC protein degradation platform | Laigo Bio, an Utrecht-based company pioneering novel and highly differentiated therapies using its proprietary SureTAC precision membrane protein degradation platform, has successfully raised €11.5 million in Seed financing. The funding rou... |
| Jul 29, 2025 | Society for Immunotherapy of Cancer Announces 2025 Annual Award Recipients | Society for Immunotherapy of Cancer The Society for Immunotherapy of Cancer (SITC) is proud to recognize individuals who have made outstanding contributions to the field of immuno-oncology. SITC is pleased to announce the recipients of its ... |
| Jul 7, 2025 | Amsterdam-based Biotech Booster receives €196.4 million to help Dutch innovations reach the market | Biotech Booster, a Dutch valorisation programme that accelerates biotechnological innovations from idea to an investable proposal, was awarded €196.4 million from the National Growth Fund. With this award, the previously conditional funding... |
| Apr 25, 2024 | Dutch-based Flindr Therapeutics secures €20M to discover and develop precision oncology therapeutics | Read this article in: Netherlands-based Flindr Therapeutics, a company focused on precision cancer treatments, announced that it has secured €20M in a Series A round of funding. This funding will help advance the Dutch company’s cancer trea... |
| Sep 1, 2021 | Single Cell Discoveries joins consortium to build a single-cell cancer atlas to find therapy resistant tumor cells |
Reviews 0
FAQ about Oncode Institute
When was Oncode Institute founded?
Oncode Institute was founded in 2017.
How much funding has Oncode Institute raised?
Oncode Institute has raised $297.89K in total across 1 funding round.
What has the press written about Oncode Institute?
Parsers VC has collected 8 articles mentioning Oncode Institute, among them “Laigo Bio: €17 Million Raised For Biotech Developing SureTACs Precision Protein Degradation Platform” (Mar 31, 2026) and “Laigo Bio Closes €17M Seed Funding” (Mar 23, 2026).
Is Oncode Institute still active?
Yes, Oncode Institute is active; its latest activity on Parsers VC dates from Mar 31, 2026.